It is not a frequent event for an editor to be able to announce a brand new journal. But we can this month. In partnership with the International AIDS Society (IAS) and with funding from Bristol-Myers Squibb, Medscape General Medicine now contains the brand-new eJIAS as another specialized eSection with its own Editor in Chief, Dr. Mark Wainberg[1] of Montreal's McGill University, and a distinguished editorial board. As you, the reader, knows, HIV/AIDS continues to be a serious epidemic; [it's] "in control," meaning steady-state, in some developed countries, but out of control in many developing countries, poised now in Asia to potentially dwarf the devastating scope of the epidemic in many African countries.
You ask, why another AIDS journal? Aren't there enough already? There are indeed many excellent journals that publish research and clinical observations about HIV. But what has been wrong is the imbalance between those countries that have the worst HIV problems and those countries that publish most of the articles. It is a developing- vs developed-world dysynchrony. This new journal, eJIAS, is free of charge to readers and to authors in all countries; being electronic, it will be fast; and it will emphasize publications from workers in developing countries. This time, for a change, the "have-nots" win. Good show! That's my opinion. I'm Dr. George Lundberg, Editor of MedGenMed.
Video.
Quicktime required to view videos
References
- 1. Wainberg MA. eJIAS: Editor's Welcome. Medscape General Medicine. 2004;6(3). Available at: http://www.medscape.com/viewarticle/482374. Accessed July 8, 2004. [PMC free article] [PubMed] [Google Scholar]
